No definition available.
Neuroendocrine tumor and carcinoma of stomach
C3_STOMACH_NEUROENDOCRINE_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to Neuroendocrine tumor and carcinoma of stomach based on the number of shared cases.
Similar with more cases:
- Neuroendocrine tumor and carcinoma of stomach
- Malignant neoplasm of stomach
- Malignant neoplasm of stomach
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 985 | 549 | 422 |
Only index persons | 756 | 449 | 307 |
Unadjusted period prevalence (%) | |||
Whole population | 0.01 | 0.02 | 0.01 |
Only index persons | 0.01 | 0.02 | 0.01 |
Median age at first event (years) | |||
Whole population | 63.39 | 62.91 | 63.76 |
Only index persons | 61.93 | 60.77 | 63.64 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 145 | 79 | 66 |
Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
Median age at first event (years) | 61.47 | 59.11 | 64.29 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint C3_STOMACH_NEUROENDOCRINE_EXALLC and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
C3_STOMACH_NEUROENDOCRINE_EXALLC | 1.835 [1.42, 2.37] | < 0.001 |
Birth year | 0.992 [0.98, 1.0] | 0.065 |
During the follow-up period (1.1.1998 — 31.12.2019), 105 out of 375 females with C3_STOMACH_NEUROENDOCRINE_EXALLC died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
C3_STOMACH_NEUROENDOCRINE_EXALLC | 2.203 [1.59, 3.05] | < 0.001 |
Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 121 out of 282 males with C3_STOMACH_NEUROENDOCRINE_EXALLC died.
Mortality risk
Mortality risk for people of age
years, who have C3_STOMACH_NEUROENDOCRINE_EXALLC.N-year risk | Females | Males |
---|---|---|
1 | 0.177% | 0.338% |
5 | 0.924% | 2.136% |
10 | 2.129% | 5.494% |
15 | 4.33% | 10.24% |
20 | 8.114% | 17.416% |
Relationships between endpoints
↥Index endpoint: C3_STOMACH_NEUROENDOCRINE_EXALLC – Neuroendocrine tumor and carcinoma of stomach
GWS hits: -